GB8719248D0 - Galenical formulations - Google Patents

Galenical formulations

Info

Publication number
GB8719248D0
GB8719248D0 GB878719248A GB8719248A GB8719248D0 GB 8719248 D0 GB8719248 D0 GB 8719248D0 GB 878719248 A GB878719248 A GB 878719248A GB 8719248 A GB8719248 A GB 8719248A GB 8719248 D0 GB8719248 D0 GB 8719248D0
Authority
GB
United Kingdom
Prior art keywords
galenical formulations
galenical
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB878719248A
Other versions
GB2193891B (en
GB2193891A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB8719248A priority Critical patent/GB2193891B/en
Publication of GB8719248D0 publication Critical patent/GB8719248D0/en
Publication of GB2193891A publication Critical patent/GB2193891A/en
Application granted granted Critical
Publication of GB2193891B publication Critical patent/GB2193891B/en
Priority to CY170494A priority patent/CY1704A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
GB8719248A 1986-08-18 1987-08-14 Nasal pharmaceutical composition containing a somatostatin anologue. Expired - Lifetime GB2193891B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB8719248A GB2193891B (en) 1986-08-18 1987-08-14 Nasal pharmaceutical composition containing a somatostatin anologue.
CY170494A CY1704A (en) 1986-08-18 1994-01-14 Nasal pharmaceutical composition containing a somatostatin anologue

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds
GB8719248A GB2193891B (en) 1986-08-18 1987-08-14 Nasal pharmaceutical composition containing a somatostatin anologue.

Publications (3)

Publication Number Publication Date
GB8719248D0 true GB8719248D0 (en) 1987-09-23
GB2193891A GB2193891A (en) 1988-02-24
GB2193891B GB2193891B (en) 1990-07-25

Family

ID=27263129

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8719248A Expired - Lifetime GB2193891B (en) 1986-08-18 1987-08-14 Nasal pharmaceutical composition containing a somatostatin anologue.

Country Status (2)

Country Link
CY (1) CY1704A (en)
GB (1) GB2193891B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5011678A (en) * 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
US5006510A (en) * 1989-06-20 1991-04-09 Ellis Wladislaw V Method for relieving chronic pain with a somatostatin analog composition
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
US5480869A (en) * 1990-01-09 1996-01-02 The Regents Of The University Of California Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
AU659328B2 (en) * 1992-06-12 1995-05-11 Teijin Limited Ultrafine powder for inhalation and production thereof
DE69330672T2 (en) * 1992-06-12 2002-06-27 Teijin Ltd PHARMACEUTICAL PREPARATION FOR APPLICATION IN THE AIRWAY
CN1155368C (en) 1996-02-27 2004-06-30 帝人株式会社 Powdery composition for nasal administration
US6228840B1 (en) 1998-02-27 2001-05-08 Edward T. Wei Melanocortin receptor antagonists and modulations of melanocortin receptor activity
US6428805B1 (en) * 1998-08-26 2002-08-06 Teijin Limited Powdery nasal compositions
PT1787658E (en) 2005-11-10 2012-06-22 Chemi Spa Sustained release formulations of somatostatin analogue inhibitors of growth hormone
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
JP2019519487A (en) 2016-05-05 2019-07-11 アクエスティブ セラピューティクス インコーポレイテッド Delivery enhancing epinephrine composition
GB2567285A (en) * 2017-08-07 2019-04-10 Suprapharm Cc Preparation for nasal-nasopharyngeal treatment
WO2019067596A1 (en) * 2017-09-26 2019-04-04 Aquestive Therapeutics, Inc. Delivery pharmaceutical compositions including permeation enhancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0029579B1 (en) * 1979-11-27 1983-02-16 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use

Also Published As

Publication number Publication date
GB2193891B (en) 1990-07-25
GB2193891A (en) 1988-02-24
CY1704A (en) 1994-01-14

Similar Documents

Publication Publication Date Title
GB8628359D0 (en) Galenical formulation
GB8613914D0 (en) Liquid formulations
ZW13587A1 (en) Pharmaceutical formulations
GB8719248D0 (en) Galenical formulations
GB8600190D0 (en) Pesticidal formulations
GB8727590D0 (en) Formulation
GB8712251D0 (en) Formulation
ZA87331B (en) Transdermal formulations
ZA876119B (en) Novel galenical formulations
GR871289B (en) Novel galenical formulations
GR871915B (en) Pharmaceutical formulations
GB8606755D0 (en) Formulations
GB8606455D0 (en) Formulations
GB8606403D0 (en) Formulation
GB8621228D0 (en) Formulation
GB8630907D0 (en) Formulation
GB8628604D0 (en) Formulation
GB8606259D0 (en) Formulation
GB8614980D0 (en) Formulation
GB8628603D0 (en) Formulation
GB8624268D0 (en) Formulation
GB8621018D0 (en) Formulation
GB8621019D0 (en) Formulation
GB8621448D0 (en) Formulation
GB8603097D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960814